DotBio is a biotechnology company focused on developing novel immuno-oncology drugs using its proprietary DotBody technology. Dot Bodies are multi-specific, humanized, and highly stable domain therapeutic antibodies that have the potential to revolutionize cancer treatment. Founded by experts in pro...See more
Headquarter Singapore |
Countries of operation Singapore |
Year founded 2018 (6 years) |
Funding status Private |
Company type SME |
Project Manager
Senior Scientist
Research Associate
Share capital injection/new funding: approx. USD 5,600,000
The company has a sophisticated ownership structure and may be part of a large corporate group
Job title | Name | Email | Country based in | Job Function | Seniority | |
---|---|---|---|---|---|---|
Project Manager | hidden.item | hidden.item | hidden.item | |||
Senior Scientist | hidden.item | hidden.item | hidden.item | |||
Research Associate | hidden.item | hidden.item | hidden.item |
Auditor: | P G WEE PARTNERSHIP LLP |
Share Capital - Ordinary shares: | hidden.item |
Sign up to view for free | |
Company | Incorporation date | Country of Registration | Share capital | Local SIC |
---|---|---|---|---|
| 6 Jun 2017 | Singapore | SGD 4,124,250 | 72101: RESEARCH AND EXPERIMENTAL DEVELOPMENT ON BIOTECHNOLOGY (EXCLUDING MEDICAL SCIENCE) |